Distinct neutralization sensitivity between adult and infant transmitted/founder HIV-1 subtype C viruses to broadly neutralizing monoclonal antibodies.
Broadly neutralizing antibodies (bnAbs), passively administered or elicited through vaccination, are a promising strategy for novel HIV prevention, treatment or inducing ART-free remission. However, HIV diversity and evolution are a barrier to the efficacy of bnAbs and there is therefore an urgent n...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-06-01
|
| Series: | PLoS Pathogens |
| Online Access: | https://doi.org/10.1371/journal.ppat.1013245 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849320314639482880 |
|---|---|
| author | Bongiwe Ndlovu Kamini Gounder Nelisiwe Zikhali Lanish Singh Ntokozo Ntshangase Nombali Gumede Jane Millar Rebecca T van Dorsten Nicholas E Grayson David Bonsall Sandra E Chaudron Jennifer Mabuka Krista L Dong Bruce D Walker Penny L Moore Philip J R Goulder Thumbi Ndung'u |
| author_facet | Bongiwe Ndlovu Kamini Gounder Nelisiwe Zikhali Lanish Singh Ntokozo Ntshangase Nombali Gumede Jane Millar Rebecca T van Dorsten Nicholas E Grayson David Bonsall Sandra E Chaudron Jennifer Mabuka Krista L Dong Bruce D Walker Penny L Moore Philip J R Goulder Thumbi Ndung'u |
| author_sort | Bongiwe Ndlovu |
| collection | DOAJ |
| description | Broadly neutralizing antibodies (bnAbs), passively administered or elicited through vaccination, are a promising strategy for novel HIV prevention, treatment or inducing ART-free remission. However, HIV diversity and evolution are a barrier to the efficacy of bnAbs and there is therefore an urgent need for continuous virus surveillance to identify bnAbs with optimal neutralization breadth and potency against transmitted/founder (TF) viruses, especially in high-burden regions. We determined the neutralization sensitivity of TF viruses isolated within seven days after first detection of heterosexually acquired infection from young women 18-23 years old (n = 39) and within 1 month after birth from in-utero infected infants (n = 21) from FRESH and Baby Cure cohorts respectively, in KwaZulu-Natal, South Africa, where HIV-1 subtype C predominates. Neutralization sensitivities of 47 viruses from FRESH and 21 viruses from Baby Cure were assessed against nine bnAbs targeting different regions on the HIV-1 Env trimer. HIV-1 env sequences within and between bnAb epitopes were compared with database. The bnAbs VRC07-523LS, CAP256-VRC26.25, PGDM1400, 10E8 and PGT151 displayed higher neutralization breadth and potency than other bnAbs against FRESH TF viruses (>70% coverage, starting concentration of 10 μg/ml). Furthermore, VRC07-523LS showed higher neutralization breadth and potency than other bnAbs against Baby Cure TF viruses (p = 0.02). Interestingly, CAP256-VRC26.25 and PGT151 had lower neutralization coverage against infant TF viruses (<60% coverage). Moreover, 40% of infants TF had escape mutations within the V2 loop compared to 28% observed in FRESH and these mutations may explain the observed differences in neutralization sensitivities. However, few mutations were observed in gp120-gp41 interface in both adults and infants. Our findings suggest that intervention studies may have to consider different antibody combinations in adult versus paediatric settings. Moreover, high transmission of escape variants in both vertical and heterosexual transmissions is of concern. This information may be important in the selection of bnAbs that will undergo clinical testing in subtype C settings. |
| format | Article |
| id | doaj-art-1c0d68d76f074e2b8bd1df5570ae3324 |
| institution | Kabale University |
| issn | 1553-7366 1553-7374 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Pathogens |
| spelling | doaj-art-1c0d68d76f074e2b8bd1df5570ae33242025-08-20T03:50:07ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742025-06-01216e101324510.1371/journal.ppat.1013245Distinct neutralization sensitivity between adult and infant transmitted/founder HIV-1 subtype C viruses to broadly neutralizing monoclonal antibodies.Bongiwe NdlovuKamini GounderNelisiwe ZikhaliLanish SinghNtokozo NtshangaseNombali GumedeJane MillarRebecca T van DorstenNicholas E GraysonDavid BonsallSandra E ChaudronJennifer MabukaKrista L DongBruce D WalkerPenny L MoorePhilip J R GoulderThumbi Ndung'uBroadly neutralizing antibodies (bnAbs), passively administered or elicited through vaccination, are a promising strategy for novel HIV prevention, treatment or inducing ART-free remission. However, HIV diversity and evolution are a barrier to the efficacy of bnAbs and there is therefore an urgent need for continuous virus surveillance to identify bnAbs with optimal neutralization breadth and potency against transmitted/founder (TF) viruses, especially in high-burden regions. We determined the neutralization sensitivity of TF viruses isolated within seven days after first detection of heterosexually acquired infection from young women 18-23 years old (n = 39) and within 1 month after birth from in-utero infected infants (n = 21) from FRESH and Baby Cure cohorts respectively, in KwaZulu-Natal, South Africa, where HIV-1 subtype C predominates. Neutralization sensitivities of 47 viruses from FRESH and 21 viruses from Baby Cure were assessed against nine bnAbs targeting different regions on the HIV-1 Env trimer. HIV-1 env sequences within and between bnAb epitopes were compared with database. The bnAbs VRC07-523LS, CAP256-VRC26.25, PGDM1400, 10E8 and PGT151 displayed higher neutralization breadth and potency than other bnAbs against FRESH TF viruses (>70% coverage, starting concentration of 10 μg/ml). Furthermore, VRC07-523LS showed higher neutralization breadth and potency than other bnAbs against Baby Cure TF viruses (p = 0.02). Interestingly, CAP256-VRC26.25 and PGT151 had lower neutralization coverage against infant TF viruses (<60% coverage). Moreover, 40% of infants TF had escape mutations within the V2 loop compared to 28% observed in FRESH and these mutations may explain the observed differences in neutralization sensitivities. However, few mutations were observed in gp120-gp41 interface in both adults and infants. Our findings suggest that intervention studies may have to consider different antibody combinations in adult versus paediatric settings. Moreover, high transmission of escape variants in both vertical and heterosexual transmissions is of concern. This information may be important in the selection of bnAbs that will undergo clinical testing in subtype C settings.https://doi.org/10.1371/journal.ppat.1013245 |
| spellingShingle | Bongiwe Ndlovu Kamini Gounder Nelisiwe Zikhali Lanish Singh Ntokozo Ntshangase Nombali Gumede Jane Millar Rebecca T van Dorsten Nicholas E Grayson David Bonsall Sandra E Chaudron Jennifer Mabuka Krista L Dong Bruce D Walker Penny L Moore Philip J R Goulder Thumbi Ndung'u Distinct neutralization sensitivity between adult and infant transmitted/founder HIV-1 subtype C viruses to broadly neutralizing monoclonal antibodies. PLoS Pathogens |
| title | Distinct neutralization sensitivity between adult and infant transmitted/founder HIV-1 subtype C viruses to broadly neutralizing monoclonal antibodies. |
| title_full | Distinct neutralization sensitivity between adult and infant transmitted/founder HIV-1 subtype C viruses to broadly neutralizing monoclonal antibodies. |
| title_fullStr | Distinct neutralization sensitivity between adult and infant transmitted/founder HIV-1 subtype C viruses to broadly neutralizing monoclonal antibodies. |
| title_full_unstemmed | Distinct neutralization sensitivity between adult and infant transmitted/founder HIV-1 subtype C viruses to broadly neutralizing monoclonal antibodies. |
| title_short | Distinct neutralization sensitivity between adult and infant transmitted/founder HIV-1 subtype C viruses to broadly neutralizing monoclonal antibodies. |
| title_sort | distinct neutralization sensitivity between adult and infant transmitted founder hiv 1 subtype c viruses to broadly neutralizing monoclonal antibodies |
| url | https://doi.org/10.1371/journal.ppat.1013245 |
| work_keys_str_mv | AT bongiwendlovu distinctneutralizationsensitivitybetweenadultandinfanttransmittedfounderhiv1subtypecvirusestobroadlyneutralizingmonoclonalantibodies AT kaminigounder distinctneutralizationsensitivitybetweenadultandinfanttransmittedfounderhiv1subtypecvirusestobroadlyneutralizingmonoclonalantibodies AT nelisiwezikhali distinctneutralizationsensitivitybetweenadultandinfanttransmittedfounderhiv1subtypecvirusestobroadlyneutralizingmonoclonalantibodies AT lanishsingh distinctneutralizationsensitivitybetweenadultandinfanttransmittedfounderhiv1subtypecvirusestobroadlyneutralizingmonoclonalantibodies AT ntokozontshangase distinctneutralizationsensitivitybetweenadultandinfanttransmittedfounderhiv1subtypecvirusestobroadlyneutralizingmonoclonalantibodies AT nombaligumede distinctneutralizationsensitivitybetweenadultandinfanttransmittedfounderhiv1subtypecvirusestobroadlyneutralizingmonoclonalantibodies AT janemillar distinctneutralizationsensitivitybetweenadultandinfanttransmittedfounderhiv1subtypecvirusestobroadlyneutralizingmonoclonalantibodies AT rebeccatvandorsten distinctneutralizationsensitivitybetweenadultandinfanttransmittedfounderhiv1subtypecvirusestobroadlyneutralizingmonoclonalantibodies AT nicholasegrayson distinctneutralizationsensitivitybetweenadultandinfanttransmittedfounderhiv1subtypecvirusestobroadlyneutralizingmonoclonalantibodies AT davidbonsall distinctneutralizationsensitivitybetweenadultandinfanttransmittedfounderhiv1subtypecvirusestobroadlyneutralizingmonoclonalantibodies AT sandraechaudron distinctneutralizationsensitivitybetweenadultandinfanttransmittedfounderhiv1subtypecvirusestobroadlyneutralizingmonoclonalantibodies AT jennifermabuka distinctneutralizationsensitivitybetweenadultandinfanttransmittedfounderhiv1subtypecvirusestobroadlyneutralizingmonoclonalantibodies AT kristaldong distinctneutralizationsensitivitybetweenadultandinfanttransmittedfounderhiv1subtypecvirusestobroadlyneutralizingmonoclonalantibodies AT brucedwalker distinctneutralizationsensitivitybetweenadultandinfanttransmittedfounderhiv1subtypecvirusestobroadlyneutralizingmonoclonalantibodies AT pennylmoore distinctneutralizationsensitivitybetweenadultandinfanttransmittedfounderhiv1subtypecvirusestobroadlyneutralizingmonoclonalantibodies AT philipjrgoulder distinctneutralizationsensitivitybetweenadultandinfanttransmittedfounderhiv1subtypecvirusestobroadlyneutralizingmonoclonalantibodies AT thumbindungu distinctneutralizationsensitivitybetweenadultandinfanttransmittedfounderhiv1subtypecvirusestobroadlyneutralizingmonoclonalantibodies |